Emerging cell-cycle inhibitors for pancreatic cancer therapy.
about
Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.
P2860
Emerging cell-cycle inhibitors for pancreatic cancer therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Emerging cell-cycle inhibitors for pancreatic cancer therapy.
@en
type
label
Emerging cell-cycle inhibitors for pancreatic cancer therapy.
@en
prefLabel
Emerging cell-cycle inhibitors for pancreatic cancer therapy.
@en
P2860
P1476
Emerging cell-cycle inhibitors for pancreatic cancer therapy.
@en
P2093
Caio M Rocha Lima
Soley Bayraktar
P2860
P304
P356
10.1517/14728214.2012.739606
P407
P577
2012-11-05T00:00:00Z